Sulpiride tablets are used to treat psychosis, strong antiemetic and inhibit gastric juice secretion. Side effects include insomnia, early awakening, headache, irritability, fatigue and loss of appetite.
Sulpiride tablets are clinically effective in the treatment of symptoms of apathy, withdrawal, rigidity, depression, hallucinations and delusions, and are applicable to the symptoms of withdrawal, withdrawal and apathy in schizophrenia simplex, paranoid, catatonic and chronic schizophrenia, and also have good efficacy in the symptoms of depression.
Common adverse reactions include insomnia, early awakening, headache, irritability, fatigue, and loss of appetite. Anticholinergic adverse reactions such as dry mouth, blurred vision, tachycardia, dysuria and constipation may occur. Extrapyramidal reactions such as tremor, rigidity, drooling, bradykinesia, inability to sit still, and acute dystonia may occur at doses greater than 600 mg (6 tablets) per day.
In addition, the drug is more likely to cause an increase in plasma concentrations of prolactin, which may be associated with symptoms such as: breast spillage, gynecomastia, menstrual disorders, amenorrhea, and weight gain. Electrocardiographic abnormalities and hepatic impairment may occur. In a small number of patients, euphoria, agitation, sleep disturbances or increased blood pressure may occur. Prolonged heavy dosing may cause delayed dyskinesia.
It is contraindicated in patients with pheochromocytoma, hypertension, severe cardiovascular disease and severe liver disease, hypersensitivity to the product. The drug is recommended for use under medical supervision to avoid adverse reactions.